Clinical trial
Role of microRNAs as Diagnostic and Prognostic Biomarkers of Neonatal Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy
NCT05986994 is registered in ClinicalTrials.gov with Ospedale Buon Consiglio Fatebenefratelli as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Role of microRNAs as Diagnostic and Prognostic Biomarkers of Neonatal Perinatal Asphyxia and Hypoxic Ischemic Encephalopathy
- Lead sponsor
- Ospedale Buon Consiglio Fatebenefratelli
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 18, 2023
- Completion date
- September 1, 2024
- Enrollment
- 45 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
asphyxia perinatal, hypoxic-ischemic encephalopathy